These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

580 related items for PubMed ID: 9815832

  • 1. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK, Farsi K, Maslak P, Kelsen DP, Spriggs D.
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [Abstract] [Full Text] [Related]

  • 2. The cyclin-dependent kinase inhibitor flavopiridol potentiates gamma-irradiation-induced apoptosis in colon and gastric cancer cells.
    Jung C, Motwani M, Kortmansky J, Sirotnak FM, She Y, Gonen M, Haimovitz-Friedman A, Schwartz GK.
    Clin Cancer Res; 2003 Dec 01; 9(16 Pt 1):6052-61. PubMed ID: 14676132
    [Abstract] [Full Text] [Related]

  • 3. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
    Motwani M, Delohery TM, Schwartz GK.
    Clin Cancer Res; 1999 Jul 01; 5(7):1876-83. PubMed ID: 10430095
    [Abstract] [Full Text] [Related]

  • 4. Potentiation of apoptosis by treatment with the protein kinase C-specific inhibitor safingol in mitomycin C-treated gastric cancer cells.
    Schwartz GK, Haimovitz-Friedman A, Dhupar SK, Ehleiter D, Maslak P, Lai L, Loganzo F, Kelsen DP, Fuks Z, Albino AP.
    J Natl Cancer Inst; 1995 Sep 20; 87(18):1394-9. PubMed ID: 7658500
    [Abstract] [Full Text] [Related]

  • 5. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R, Tanabe K, Emi M, Uchida Y, Osaki A, Toge T.
    Int J Oncol; 2005 Apr 20; 26(4):1025-31. PubMed ID: 15753998
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Flavopiridol induces cellular FLICE-inhibitory protein degradation by the proteasome and promotes TRAIL-induced early signaling and apoptosis in breast tumor cells.
    Palacios C, Yerbes R, López-Rivas A.
    Cancer Res; 2006 Sep 01; 66(17):8858-69. PubMed ID: 16951203
    [Abstract] [Full Text] [Related]

  • 8. Flavopiridol: a cytotoxic flavone that induces cell death in noncycling A549 human lung carcinoma cells.
    Bible KC, Kaufmann SH.
    Cancer Res; 1996 Nov 01; 56(21):4856-61. PubMed ID: 8895733
    [Abstract] [Full Text] [Related]

  • 9. Rapid induction of apoptosis by combination of flavopiridol and tumor necrosis factor (TNF)-alpha or TNF-related apoptosis-inducing ligand in human cancer cell lines.
    Kim DM, Koo SY, Jeon K, Kim MH, Lee J, Hong CY, Jeong S.
    Cancer Res; 2003 Feb 01; 63(3):621-6. PubMed ID: 12566305
    [Abstract] [Full Text] [Related]

  • 10. Flavopiridol, an inhibitor of cyclin-dependent kinases, induces growth inhibition and apoptosis in bladder cancer cells in vitro and in vivo.
    Wirger A, Perabo FG, Burgemeister S, Haase L, Schmidt DH, Doehn C, Mueller SC, Jocham D.
    Anticancer Res; 2005 Feb 01; 25(6B):4341-7. PubMed ID: 16309238
    [Abstract] [Full Text] [Related]

  • 11. Induction of apoptosis and inhibition of c-erbB-2 in breast cancer cells by flavopiridol.
    Li Y, Bhuiyan M, Alhasan S, Senderowicz AM, Sarkar FH.
    Clin Cancer Res; 2000 Jan 01; 6(1):223-9. PubMed ID: 10656453
    [Abstract] [Full Text] [Related]

  • 12. Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis.
    Hsueh CT, Chiu CF, Kelsen DP, Schwartz GK.
    Cancer Chemother Pharmacol; 2000 Jan 01; 45(5):389-96. PubMed ID: 10803922
    [Abstract] [Full Text] [Related]

  • 13. Flavopiridol down-regulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis.
    Wittmann S, Bali P, Donapaty S, Nimmanapalli R, Guo F, Yamaguchi H, Huang M, Jove R, Wang HG, Bhalla K.
    Cancer Res; 2003 Jan 01; 63(1):93-9. PubMed ID: 12517783
    [Abstract] [Full Text] [Related]

  • 14. Improvement of esophageal adenocarcinoma cell and xenograft responses to radiation by targeting cyclin-dependent kinases.
    Raju U, Ariga H, Koto M, Lu X, Pickett J, Valdecanas D, Mason KA, Milas L.
    Radiother Oncol; 2006 Aug 01; 80(2):185-91. PubMed ID: 16905211
    [Abstract] [Full Text] [Related]

  • 15. Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatment.
    Bright SA, Campiani G, Deininger MW, Lawler M, Williams DC, Zisterer DM.
    Biochem Pharmacol; 2010 Jul 01; 80(1):31-8. PubMed ID: 20206141
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic synergy between flavopiridol (NSC 649890, L86-8275) and various antineoplastic agents: the importance of sequence of administration.
    Bible KC, Kaufmann SH.
    Cancer Res; 1997 Aug 15; 57(16):3375-80. PubMed ID: 9269999
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic effect of flavopiridol, a small molecular cyclin-dependent kinase inhibitor, in human ovarian carcinoma].
    Song Y, Shen K, Tang PP.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Nov 15; 42(11):761-4. PubMed ID: 18307904
    [Abstract] [Full Text] [Related]

  • 18. The cyclin-dependent kinase inhibitor (CDKI) flavopiridol disrupts phorbol 12-myristate 13-acetate-induced differentiation and CDKI expression while enhancing apoptosis in human myeloid leukemia cells.
    Cartee L, Wang Z, Decker RH, Chellappan SP, Fusaro G, Hirsch KG, Sankala HM, Dent P, Grant S.
    Cancer Res; 2001 Mar 15; 61(6):2583-91. PubMed ID: 11289135
    [Abstract] [Full Text] [Related]

  • 19. Flavopiridol potentiates STI571-induced mitochondrial damage and apoptosis in BCR-ABL-positive human leukemia cells.
    Yu C, Krystal G, Dent P, Grant S.
    Clin Cancer Res; 2002 Sep 15; 8(9):2976-84. PubMed ID: 12231544
    [Abstract] [Full Text] [Related]

  • 20. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R.
    Int J Oncol; 2004 Mar 15; 24(3):591-608. PubMed ID: 14767544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.